Titanium is notable for its biocompatibility and is used as biologic implant material across surgical specialties, especially in metal-sensitive individuals. However, rare cases of titanium hypersensitivity reactions are reported in the literature. This article discusses the properties and biological behavior of titanium and provides a thorough review of the literature on reported cases, diagnostic techniques, and approach to management of titanium hypersensitivity.
Properties of Titanium and Its Alloys
This lustrous transitional metal is renowned for its high strengthto-weight ratio, low modulus of elasticity, corrosion resistance, and biocompatibility. It exists in 2 configurations: (1) > type (hexagonal crystalline structure) at room temperature and (2) A type (body-centered cubic crystalline structure) with a phase transition temperature of 882-C. Titanium (Ti) is classified as either commercially pure titanium (CpTi) or a titanium alloy (Table 1) . 2, 3 Commercially pure titanium has tensile strength equal to that of low-grade stainless steel, yet it is 45% less dense. Grade 2 CpTi (99.3% pure) is overwhelmingly the most popular in medical device production. 4 It is important to recognize that all CpTi has been shown to contain a small yet consistent percentage of detectable impurities, such as the elements aluminum (Al), beryllium (Be), cadmium(Cd), cobalt (Co), chromium (Cr), copper (Cu), iron (Fe), hafnium (Hf ), manganese (Mn), molybdenum (Mo), nickel (Ni), palladium (Pd), and vanadium (V). 5 The presence of these trace elements is believed to be negligible from a metallurgical standpoint but may potentially be significant enough to cause an allergic reaction in an already sensitized patient.
Alloys
Alloy elements may be added to Ti to manipulate its properties for optimum performance. Alloy elements can be classified into > stabilizers, A stabilizers, and > + A stabilizers (Table 1) . 2, 3 Increasing the >-phase improves weldability and high-temperature stability, whereas increasing the A-phase increases room temperature strength and enhances the durability of medical device implants. Currently, commercially pure titanium and > + AYtype noble (precious metal) alloys, such as Ti-6Al-4V ELI (extra low level of interstitial content) are widely used for medical and dental implant materials. More recently, vanadium-free alloys have been developed (Ti-6Al-7Nb and Ti-5Al-3Mo-4Zr), which exhibit equally good mechanical properties. In addition, more costeffective nonnoble alloys such as Ni-Ti (NITINOL [NITINOL was named for its elemental components and place of origin: NIckel TItanium Naval Ordinance Laboratory]) and Ti-Co have also been developed. 4 (Continued on next page) Least popular in all industries due to poor corrosion resistance 4 99.0% Pure, extra-high oxygen content Serves mainly in aerospace/aircraft industry, some dental implants Commercially pure modified with palladium or ruthenium (> phase) 7 99.4% Pure, plus 0.12%-0.25% palladium 7H
Grade 7 with 58 ksi (400 MPa) minimum UTS 11 Unalloyed titanium plus 0.12%-0.25% palladium 16 Unalloyed titanium plus 0.04%-0.08% palladium 16H
Grade 16 with 58 ksi (400 MPa) minimum UTS 17 Unalloyed titanium plus 0.04%-0.08% palladium 26 Unalloyed titanium plus 0.08%-0.14% ruthenium 26H
Grade 26 with 58 ksi (400 MPa) minimum UTS 27 Unalloyed titanium plus 0.08%-0.14% ruthenium > And near-> alloys > Stabilizers: Al, Sn, Ga, Zr, C, O, N 12 Ti-0.3Mo-0.8Ni 6
Ti-5Al-2.5Sn Ti-5Al-5Sn with ELI 9
Ti-3Al-2.5 V 18
Ti-3Al-2.5 V, plus 0.04%-0.08% palladium 28 Ti-3Al-2.5 V, plus 0.08%-0.14% ruthenium Ti8Al-1Mo-1 V Ti-6Al-2Nb-1Ta-0.8Mo Ti-2.25Al-11Sn-5Zr-1Mo Ti-5.8Al-4Sn-3.5Zr-0.7Nb-0.5Mo-0.35Si > + A Alloys 5 Ti-6Al-4V Widely used in dental and medical industry 23 Ti-6Al-4V-ELI Widely used in dental and medical industry 24 Ti-6Al-4V, plus 0.04%-0.08% palladium 25 Ti-6Al-4V, plus 0.3%-0.8% nickel and 0.04%-0.08% palladium 29 Ti-6Al-4V-ELI, plus 0.08%-0.14% ruthenium Ti-6Al-7Nb
Developed as a substitute for Ti-6Al-4V due to vanadium's potential biotoxicity Ti-5Al-3Mo-4Zr Ti-6Al-6 V-2Sn Ti-8Mn Ti-7Al-4Mo Ti-6Al-2Sn-4Zr-6Mo Ti-5Al-2Sn-2Zr-4Mo-4Cr Ti-6Al-2Sn-2Zr-2Mo-2Cr Ti-3Al-2.5 V Ti-4Al-4Mo-2Sn-0.5Si rather as TiO 2 powder for its whitening effect, sunscreen properties, and use as a safe excipient in cosmetic, pharmaceutical, and food industries. 6 
Metal Hypersensitivity
Metal hypersensitivity is typically characterized as a type IV hypersensitivity reaction, with a sensitization phase upon first exposure followed by an elicitation of an immune response on subsequent exposure of sufficient concentrations. In order to become allergenic, metal ions require binding with native proteins to form antigenic hapten complexes. These complexes are then processed by antigen-presenting cells and presented to T cells. 7 Sensitization typically occurs through contact with skin but could also theoretically occur through systemic exposure via ingestion or corrosion of a metal implant. 6, 8 The elicitation phase classically presents as a cutaneous allergic contact dermatitis, manifesting in the skin as dermatitis with pruritus, edema, and erythema in mild cases and vesicle and bullae formation in more severe cases.
Hypersensitivity to metal in the general population is common, affecting up to 15.5% of patch-tested patients in North America 9 and up to 20% in Western Europe. 10 The biggest offender is nickel, followed by cobalt and chromium. It is postulated that sensitivity to nickel develops from cutaneous exposures to common everyday items, such as belt buckles, fasteners, and jewelry. The significantly higher incidence of nickel sensitivity in women is thought to be attributable to increased jewelry use; the number of piercings is also significantly associated with nickel sensitivity in both genders. 11 The relationship between preexisting metal sensitivity and implantrelated contact dermatitis or implant failure remains unclear and therefore nearly impossible to predict. The exact cellular pathways involved in the elicitation of systemic metal hypersensitivity reactions have not yet been well established; however, reports of abundant macrophages and T lymphocytes and absence of B lymphocytes in recovered tissues surrounding failed metal implants suggest a possible type IV hypersensitivity reaction. 6, 12 In addition, increased levels of cytokines such as interferon F, interleukin 6 (IL-6) and IL-17 have been observed in metal-sensitive patients. 13Y15
Systemic Contact Dermatitis
Systemic contact dermatitis is classically defined as a condition where an individual sensitized to an allergy through the cutaneous route subsequently reacts to contact with the same allergen via a systemic route. 16 Internal contact with metal ions may occur through corrosion of an implanted metal device. A thorough review of more than 55 reported cases of systemic contact dermatitis is described elsewhere. 17 Symptoms of systemic contact dermatitis may manifest as an eczematous rash at the site of previous external exposure (patch test or jewelry adornment site), generalized eczema, hand dermatitis, erythroderma, vasculitis-like lesions, or flexural exanthema (also known as ''baboon syndrome''). 15, 16 Titanium in the Biologic Environment Titanium is a nonessential mineral; it is not required for metabolism or growth and does not serve as a cofactor in any known Ti-3Al-8 V-6Cr-4Zr-4Mo, plus 0.04%-0.08% palladium 21
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Ti-5Al-1Sn-1Zr-1 V-0.8Mo Ni-Ti Also known as NITINOL human enzymatic process. Although titanium is ubiquitous in the modern world, sensitivity to titanium is exceedingly uncommon. This can be explained by the fact that contact with titanium is almost entirely in its TiO 2 form, which is water insoluble, does not bind to cells or proteins, 18 does not penetrate the skin, 19, 20 and is not absorbed by the gastrointestinal tract.
Corrosion
Contrary to the past reputation of titanium as an ''inert'' metal, it is now well accepted that no metal is completely inert. Corrosion rates for passivated Ti are typically less than 0.02 mm/y, well below the 0.13-mm/y maximum corrosion rate commonly accepted for biomaterial design and application. 21 Corrosion of Ti and Ti alloys releases Ti(IV) ions, as well as vanadium, aluminum, niobium, molybdenum, and trace element ions such as nickel. 21, 22 Accelerated corrosion of titanium has been observed in the presence of a number of corrosive species such as hydrogen ions (H + ), sulfide compounds (S 2j ), dissolved oxygen (O 2 ), radical oxygen species and chloride ions (Cl j ), all which can be present in the biologic milieu. 23 Like other metal ions, single titanium ions alone are not antigenic; however, titanium ions from corrosion products or salts can bind to cellular and serum human proteins, specifically transferrin and albumin, and create haptenic antigens that elicit immune responses. 17,24Y26 The most commonly observed types of titanium corrosion in the biologic environment include mechanical wear processes, physiochemical corrosion, and cellular-gated mechanisms. Dissolved metal ions can accumulate in the tissue surrounding the implants or can be released into circulation and accumulate in distal organs or be excreted by the kidneys. 20, 27, 28 Cellular Response Small particles of TiO 2 (G10 Km) are phagocytized by polymorphonuclear leukocytes, activating the cells that in turn produce highly reactive oxygen metabolites, 29 a fact that can explain recently described bactericidal properties of titanium 30 and, theoretically, accelerated biocorrosion. The phagocytosis of metal wear particles by tissue macrophages induces production of proinflammatory cytokines that may enhance osteolytic activity at the implant-bone interface. 31, 32 Titanium ions themselves can directly induce the differentiation of osteoclast precursors toward mature osteoclasts capable of effective bone resorption. 33 Titanium ions have also been shown to have a strong affinity for phosphorylated proteins, which has led researchers to postulate that they may interfere with cell signaling and/or alter forms of selfantigens, thereby causing autoimmune-like activity. 20 Titanium particles have been observed inside macrophage lysosomes in reports of type IV hypersensitivity. 34Y36 In addition, cells necessary for the development of type IV hypersensitivity have been found in perivascular tissue adjacent to failed implants 27 ; however, this finding has also been reported in patients with asymptomatic implants at routine explantation. 37 
Tissue Response
Once phagocytized, titanium particles can remain in tissues after the macrophages have been surrounded by collagenous tissues and finally perish. 35 Dark, blackish-brown staining of tissues surrounding titanium implants has been reported. 27, 38 It is believed that if wear damages the TiO 2 surface, it rapidly reforms (repassivates), producing so much oxide that the surrounding tissues turn black. 39 This dark tissue discoloration has been reported in both well-functioning as well as failed titanium implants and is considered by itself to be harmless. 40 In addition to local release from implants, there have been reports of the deposition of titanium particles in regional lymph nodes. Onodera et al 41 reported a submandibular lymph node with titanium particles 2 years after a mandibular titanium plate implant in a 41-year-old man. Weingart et al 42 documented 12 of 19 dogs with titanium particles in regional lymph nodes 9 months after maxilla/ mandible titanium screw implantation.
Titanium Implants
Titanium is routinely used to manufacture implantable metal devices for a wide variety of applications, including dental, orthopedic, and cardiac implants. It is therefore subject to diverse biological microenvironments capable of delivering variable physiologic and mechanical stressors. There are several types of orthopedic implants ( Table 2) , 43 each with varying potential for biocorrosive stimuli. For example, the dynamic implants of joint replacements have to withstand completely different forces than static implants used for osteosynthesis. Thus, large implant-derived particles (in the nanometer range) are produced exclusively by the mechanical wear process in articular coupling of prostheses and are not observed with osteosynthesis implants. At the same time, both joint replacement implants and osteosynthesis implants are exposed to similar biological activity and electrochemical processes that can lead to ion release. 20 In a recent in vitro oral implant corrosion study, researchers showed that salivary proteins appeared to spontaneously enhance the formation of a passive film layer on the surface of pure titanium implants, resulting in highly stable behavior of the metal. 44 On the other hand, the human stomatognathic system is subjected to varying changes in pH and temperature. 21 This dynamic microenvironment allows for unpredictable conditions that may actually enable biocorrosion.
Detection of Titanium in Serum
Several studies have found that serum metal levels, including titanium, are higher in patients with failed joints as compared with controls. Jacobs et al 45 evaluated 8 patients with failed titanium alloy cementless total knee arthroplasty (TKA) patellar components and found that serum concentrations of titanium were 50 times higher than those in 21 control subjects without implants; a separate cohort of 21 patients with loose total hip arthroplasty (THA) Ti6Al4V implants found that titanium serum levels were twice that of 21 controls. 46 Leopold et al 46 described a patient with a titanium alloy TKA that functioned well for 10 years; because of painless squeaking, the joint was replaced. The explanted artificial joint showed that the polyethylene portion of the patellar component had worn through, causing direct titanium metal wear and corrosion. Titanium serum level at the time of joint removal was 98 times higher than a year earlier, when the joint was asymptomatic. 47 Correlation between serum ion concentration and lymphocyte reactivity has also been demonstrated, suggesting that in vivo metal release may be associated with joint replacement failure. 48 Diagnostic Testing for Titanium Allergy 
Patch Test
Patch testing is the most widely used in vivo method to test for type IV sensitivity reactions to potential contact allergens. There are several patch test screening series including the Food and Drug AdministrationYapproved TRUE Test, the American Contact Dermatitis Society's Core Panel, 49 and the European Baseline Series, 50 none of which include titanium. Various extended metal and prosthesis allergen series have been suggested; all include some form of titanium. 51, 52 The literature on titanium patch-testing reports an assortment of powders, solutions, and ointments used at varying concentrations, as well as CpTi and Ti alloy sensitivity disks provided by implant manufacturers (Table 3) . 7,27,51,53Y69 Positive patch test reactions to titanium materials are extremely rare. This is not surprising, given that TiO 2 (the most common patch test formulation) has been shown not to penetrate the epidermis in healthy 18, 70 or even psoriatic skin. 19 Lhotka et al 53 reported positive patch tests to TiO 2 in a group of patients with a history of skin-penetrating surgical skin clips containing titanium. Other researchers reported positive patch tests using unique formulations of titanium. For example, researchers reported that 
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(United Kingdom) 30 Patients: 11 with a prior adverse reaction to ATL, 10 who had been previously exposed to ATL with no reaction, and 9 who had never been exposed 2 patients with unexplained THA failures patch tested negative to 12 different typical preparations of titanium, but curiously tested positive to a ''napkin cream''called metanium ointment, containing 20% TiO 2 , 5% titanium peroxide, 3% titanium salicylate, and 0.1% titanium tannate in silicone paraffin. 27 An 8-year-old atopic girl who needed a dental brace patch tested negative to titanium and TiO 2 10% in petroleum, but tested positive to titanium nitride and titanium oxalate; importantly, the authors raised concerns regarding impurities present in the testing medium. 71 A routine skin irritancy study involving a novel antiperspirant formulation spawned the investigation of utilizing a new substance for titanium patch testing, a complex titanium salt, consisting of ammonium titanium lactate. This salt appeared to have elicited type IV hypersensitivity reactions in 11 of 23 volunteer subjects with reproducible results upon patch testing later in parallel with 19 negative control volunteers, 10 of whom had been previously exposed to the salt without adverse reactions. 67 In an attempt to establish a standard patch test for titanium, a research group in Japan recommended Ti(SO 4 ) and TiCl 4 , both in 0.1% and 0.2% solutions, as useful reagents for titanium skin patch tests. They based this recommendation on the fact that they observed positive reactions in 3 of 145 metal-sensitive patients and negative reactions in 15 healthy volunteers. 55 However, it is well known that metal chlorides are potential irritants even at low concentrations, and positive reactions on patch testing may not represent allergenicity. 72 For example, TiCl 4 is the intermediate compound in the production of titanium dioxide, and when mixed with waterVeven when that water is in the form of perspirationVwill generate a vigorous exothermic reaction that yields heat and hydrochloric acid, both of which are sources of potential skin damage. 73 In fact, severe burn injuries have been reported upon exposure to this compound. 72, 74, 75 It is possible that reported hypersensitivity reactions to a titanium disk with artificial sweat actually represent metal chloride irritant reactions. 76 Currently, there remains no reliable patch test for titanium.
Lymphocyte Transformation Test
The LTT is an in vitro measurement of the proliferation response of lymphocytes following antigen-specific activation. A radioactive [H 3 ]-thymidine marker quantifies the proliferation response by measurement of the incorporated radioactivity over 5 to 7 days and is reported as a stimulation index (SI). This index is calculated from the quotient of test counts per minute over the average counts per minute from 3 negative controls. An SI of less than 2 is considered negative, SI 2 to 3 suggests possible sensitization and SI of 3 or greater indicates positive sensitization. 77, 78 A positive control assay is typically performed with mitogenic phytohemagglutinin. For quality control, morphological analysis is often performed to confirm the presence of lymphoblasts in positive reactions and to exclude cytotoxicity in negative reactions.
An optimized, commercially available LTT test called Memory Lymphocyte Immunostimulation Assay (MELISA) was developed by Astra Pharmaceuticals (now AstraZeneca) in Södertälje, Sweden. It differs by the use of defibrinated blood instead of anticoagulant-treated blood, the cultivation of lymphocytes in cultures of 1 Â 10 6 cells instead of 2 Â 10 5 (macrocultures instead of microcultures), and a double reduction of adherent cells (monocytes/macrophages) at the start and at the end of cultivation. In addition, the use of inactivated human serum instead of fetal calf serum makes MELISA more sensitive by decreasing spontaneous proliferation in control cultures. 79 As an in vitro method, LTTs offer unique benefits. Unlike patch testing, LTT cannot induce sensitization. It also has the ability to evaluate circulating lymphocytes in addition to those specifically targeted to the skin, enabling it to detect both dermally and nondermally sensitized immune cells. Challenges for widespread use include cost, limited number of antigens that may be tested, and availability of specialized laboratories. Perhaps the most important limitation is the frequent lack of clinical correlation; acceptance by dermatologists is not widespread.
Only a handful of articles have been published with data on LTT testing for titanium allergy (Table 4) . 47,59,61,62,76,77,80Y84 Three studies by the same research group reported no positive results to titanium in any of 97 total patients, both with and without metal sensitivity. However, the authors disclosed that high-enough concentrations to activate the lymphocytes may not have been achieved because of solubility issues. 47, 80, 81 Most positive results reported utilized the MELISA technique. 59, 61, 76, 77, 79, 83 There is a significantly greater prevalence of titanium hypersensitivity detected by MELISA than by patch testing, which is consistent with past reported investigations of other allergens; some authors attribute this to a greater sensitivity of this test for systemic reactions. 85, 86 A recent prospective analysis assessing metal sensitivity in patients with THA reported 35% of their patients to be positive to titanium on LTT, all of whom patch tested negative. 62 Another study by Müller and Valentine-Thon 61 including 56 patients with various health problems after receiving titanium implants observed similar results; they found that 37.5% of their patients tested positive to titanium on LTT, all of whom patch tested negative as well. Removal of the implants resulted in dramatic improvement of clinical symptoms in 54 of the 56 patients (2 chose not to undergo the procedure). Interestingly, they also observed normalization of LTT response following implant removal. 61 
Other Tests
Other testing methods reported for metal hypersensitivity include lymphocyte migration inhibition, 87 intradermal testing, 88 BiDORT, 89, 90 and a proposed triple assay consisting of (1) LTT, (2) cytokine analysis using enzyme-linked immunosorbent assay (ELISA), and (3) migration inhibition assay. 80 Yamauchi et al 91 reported a man with new-onset widespread nummular eczema and localized dermatitis overlying a newly implanted titaniumcontaining pacemaker who had negative patch tests to the pacemaker components including titanium; however, an intradermal test using the patient's serum, which had been incubated for a month with small titanium fragments, was positive. Sicilia et al 66 found that 7 of their 9 patients who were patch test positive to titanium also had type I hypersensitivity on prick testing.
Reported Adverse Reactions to Titanium
The first reported titanium hypersensitivity reactions to implants involved cardiac pacemakers in the 1980s. Over the years, additional cases of titanium hypersensitivity have been reported in other settings such as occupational inhalation, dental implants, osteosynthesis, joint replacements, surgical clips, jewelry, cranioplasty, Amplatz occluder, and suture anchors ( Table 5) . 70, 75, 89, 90 ,92Y109 A wide range of clinical manifestations have been reported, including local and/or generalized eczema, pruritus, pain, swelling, impaired fracture healing, DRESS (drug rash with eosinophilia and systemic symptoms) syndrome, sterile necrosis, unexplained implant failure, and even death. In most cases, allergy testing was performed with varying and somewhat unreliable results. Diagnosis was largely confirmed by the absence of other potential allergenic triggers and/or absence of other positive diagnostic allergy testing, in conjunction with resolution of clinical symptoms once the titanium exposure was eliminated.
Pacemaker Case Reports
Our literature search found 9 reports of suspected sensitivity to titanium in pacemakers. Three reported positive patch tests to titanium; these 3 pacemakers were removed and replaced with pacemakers coated with silicone (unsuccessful), 94 parylene (unsuccessful), 75 and polytetrafluoroethylene (PTFE) (successful). 96 The outcome of 2 of the 9 cases were not reported. 90, 91 One patient died, 92 1 resolved within 4 weeks of implant removal, 93 1 patient had spontaneous resolution without removal of the implant, 95 and another had successful replacement with a goldcoated pacemaker. 97 
Dental Implant Case Reports
Three cases of reactions to titanium-containing dental implants describe facial eczema, 100 gingival hyperplasia, 98 and pain/swelling/ erythema with granulomatous reaction surrounding the implants. 99 Patch testing was not performed in these cases; 1 reported a positive LLT. 100 Two had complete resolution after removal of the implants 98, 100 ; follow-up was not reported in the other case. 99 Some dental experts believe that oral-implantYrelated titanium hypersensitivity is currently underreported because of failure to recognize it as a potential etiological factor 110 and that it should be taken into consideration with unexplained failure cases such as spontaneous rapid exfoliation of Ti implants, 111 and/or successive dental implant failures in some patients known as ''cluster patients.'' 112, 113 Orthopedic Implant Case Reports Three case reports of reactions to orthopedic devices have been reported. Thomas and colleagues 101 reported a patient with impaired fracture healing and local eczema over the site of a titaniumbased osteosynthesis plate. Although patch testing to titanium was negative, the LTT was positive. After removal of the titanium plate, the dermatitis resolved, and the LTT returned to normal levels. 101 Chromium was detected in the commercial Ti allergens (0.21-10.82 ppm), raising concern for the role of impurities in Ti patch testing.
Opstal and Verheyden 102 reported a patient with pain, swelling, dermatitis, and double implant failure of a TKA composed of separate oxinium and titanium components. Although patch testing to titanium was negative, both implant failures were found to be due to aseptic loosening of the titanium component exclusively, as seen on imaging and at 2 revision surgeries. After replacing the titanium with a custom oxinium counterpart, clinical symptoms resolved, and the new implant did not loosen. 102 The third case, reported by Goto et al, 103 described a patient with erythema and itching of the face, trunk, and hands who had negative patch tests to metal components but whose symptoms resolved after removal of rotator cuff suture anchors composed of a titanium alloy.
Neurosurgical Implant Case Reports
Two serious reactions have been alleged to be due to titanium hypersensitivity in neurosurgical implants. Nawaz et al 104 described a previously healthy 19-year-old man, who had DRESS syndrome with interstitial nephritis after acquiring a Ti6Al4V spinal bioprosthesis. Association with the titanium implant was suspected, and patch testing revealed a ''strongly positive'' reaction to titanium and nickel. Extensive fibrosis precluded removal of the implant, and the patient was medically managed with a slow oral corticosteroid taper over 6 months. Hettige and Norris 105 reported a 64-year-old woman with a history of nickel allergy who died of diffuse brain swelling after undergoing cranioplasty with a titanium skull plate. Postmortem examination revealed high blood levels of mast cell tryptase, suggesting a massive immune reaction with no other source identified.
Cardiovascular Implant Case Reports
Belohlavek et al 108 reported a 40-year-old woman with patent foramen ovale requiring a nitinol Amplatz occluder, who subsequently developed a generalized exanthema, as well as a reported increased sensitivity (contact dermatitis) to titanium earrings and a new oral burning sensation after consumption of certain foods. MELISA testing was strongly positive to titanium trichloride (30.9) and titanium dioxide (11.2) and mildly positive to nickel (3.5) . Her symptoms were so debilitating, removal of the implant was performed, requiring an open-heart procedure. Three days after removal, her clinical symptoms resolved. 108 
Pulmonary Disease
A case of granulomatous pulmonary disease with associated pulmonary deposition of titanium was reported in a 45-year-old man who worked as a furnace feeder for an aluminum smelting company; his job involved chronic exposure to various metallic fumes and dusts. Lymphocyte transformation testing was positive to titanium, but not to any other metal particulates retrieved from his lung tissue. The researchers also demonstrated negative LTT results in 3 occupational painters as control subjects, who were also chronically exposed to titanium-based paint fumes, but who had no observed pulmonary hypersensitivity reactions. 106 Pulmonary alveolar proteinosis causing lung tissue damage has also been reported because of chronic inhalation of titanium particles from paint fumes. 114, 115 Although it is notable that the cause was attributed to titanium, the pathogenesis of pulmonary alveolar proteinosis is still unknown and therefore will not be further discussed under the umbrella of type IV hypersensitivity reactions.
Titanium in Personal Care Products
A comprehensive literature search found no reported cases of hypersensitivity to titanium in personal care products such as sunscreen and cosmetics. However, a case report of a woman with a history of atopic dermatitis and breast cancer, who had a hypersensitivity reaction to her titanium surgical clips, subsequently reported increased sensitivity to cosmetics with high titanium dioxide content. 89 
Differential Diagnoses
Sensitivity to other metals or materials may masquerade as titanium sensitivity ( Table 6 ). 116Y122 A report of pacemaker dermatitis in 1980 revealed that the stainless-steel screws in the device were inciting contact allergy to nickel, chromium, and cobalt, but not to titanium. 115 Another case of pacemaker dermatitis initially thought to be due to titanium was found to be due to epoxy resin. 116 More recently, 2 cases of contact dermatitis due to titanium spectacle frames reportedly determined that the actual allergens were nickel and/or palladium present in the ''titanium'' material. 117, 118 An informative case of impaired wound healing following osteosynthesis discovered that the causative allergen was actually a significant amount of nickel in the ''commercially pure'' titanium devices used. 119 A case of allergic contact stomatitis was determined to be due to the titanium-nitride coating on dental implant abutments and completely resolved once the implants were replaced with CpTi abutments. 120 A more straightforward case of severe contact dermatitis due to a titanium alloy (Ti-6Al-4V) halo fixation pins reported clearly positive patch test results to vanadium (a major component of the alloy). 121 
Management
The criterion standard for managing type IV hypersensitivity is avoidance of the responsible allergen. If a patient with a titanium implant presents with significant clinical symptoms strongly suggestive of titanium hypersensitivity, removal of the implant, if possible, may be considered. However, many titanium implants are intended to function for the remaining lifetime of the patient, and removal of the device may result in significant morbidity, loss of essential function, or even mortality. In these clinical scenarios, risks and benefits will need to be carefully weighed. Titanium is currently considered to be the most biocompatible metal and is often reserved as a last resort for implants in patients with metal hypersensitivity. Zirconium, gold, and oxinium replacements may be considered. Oliva and colleagues reported a patient with amelogenesis imperfecta, who required full-mouth dental implants; titanium (and other metal sensitivity) was diagnosed based on elevated MELISA levels. Zirconium oxide implants and restorations were utilized with no complications at a 3-year follow-up. 123 Custom-fabricated gold dental implants resulted in resolution of persistent gingival hyperplasia after replacing a prior titanium implant. 98 Oxinium has successfully replaced titanium in a case of TKA with aseptic loosening, as described previously. 102 Successful replacement of pacemakers with gold-coated devices, 97 as well as wrapping with PTFE sheets, 96 has been described in cases of titanium pacemaker dermatitis. Medical management has also been reported. After 3 unsuccessful pacemaker implant attempts in a 10-year-old girl because of titanium hypersensitivity (including a failed attempt at coating the pacemaker case with silicone), the patient was managed medically with oral atropine sulfate every 6 hours with adequate control. 94 Authors of the titanium implantYinduced DRESS syndrome case reported successful medical management with 6-month taper of oral corticosteroids, after determining that the implant could not be surgically removed because of extensive fibrosis. 104 Various techniques in tissue engineering to replace cartilage may someday be a valid alternative to joint arthroplasty in patients with degenerative joint diseaseVwith or without metal hypersensitivityV but research is still in its infancy. Success of stem cell therapy for osteochondral defects in animals in vivo is well established, although there is currently only a small body of evidence in human subjects. 124 The procedure involves taking autologous bone marrowYderived mesenchymal stem cells from the iliac crest and implanting them into the diseased articular space in an effort to heal cartilage or joint pathology. A review of 844 mesenchymal stem cell implant procedures and reported adverse events concluded that the procedure appears to be safe. 125 Multiple research groups are currently recruiting patients for larger clinical trials. 126 
Controversy Regarding Metal Sensitivity Testing for Implants
In general, diagnostic evaluation for allergy to implanted metallic devices is controversial. It is unresolved whether a cutaneous type IV hypersensitivity reaction has any clinical correlation with a peri-implant hypersensitivity reaction, as antigen-presenting cells in the skin (dendritic cells) differ from those in deeper tissues. Thyssen et al 127 demonstrated that the overall risk of developing extracutaneous allergic reactions following THA is comparable in metal patch testYpositive and patch testYnegative subjects. Swiontkowski et al 128 showed that the conversion from negative to positive metal patch test reactivity (chromium, nickel, and cobalt) in 242 patients before and after stainless-steel implant surgery was similar to the rate of conversion of positive to negative patch tests; in that study, patch tests were read at 48 hours only and, for the postsurgery tests, were read by the patient.
With lack of an evidence-based approach, expert opinions are sought as to when, how, and on whom patch testing should be performed. There are heterogeneous attitudes in the dermatological community regarding preimplantation evaluation for metallic devices. Most agree that individuals without a reported history of metal hypersensitivity reactions need not be screened prior to device implantation. 129 A survey conducted at the European Society of Contact Dermatitis and American Contact Dermatitis Society meetings revealed that of 119 respondents, 54% of patch-testing dermatologists believe that a patient with suspected moderate to severe metal dermatitis should undergo patch testing and/or LTT before implantation of a metallic device. 130 Thirty-eight percent agreed with a German consensus panel of dermatologists, allergists, and orthopedic surgeons that it is adequate to counsel the patient and surgeon to just use a titanium device in anyone with a history of metal allergy. 131 If metal hypersensitivity to implanted metals occurs, it is unclear whether metal hypersensitivity induces implant failure or implant failure results in metal hypersensitivity. A Delphi consensus study among orthopedic arthroplasty surgeons in the United Kingdom concluded not only that routine metal allergy screening prior to joint arthroplasty is not essential, but also that the use of traditional cobalt chromium/stainless-steel implants is recommended regardless of the patient's metal allergy status. 132 Although most patients with a preexisting metal allergy will do well despite implant allergen exposure, completely ignoring history of prior metal allergy could expose a small number of patients to the potential morbidity of a failed device as well as increased costs in further management. In some cases, disregarding a history of known allergies in a patient who subsequently develops complications could lead to legal actions against treating physicians, especially in the United States. Recent reviews have proposed a pragmatic approach, as well as a diagnostic algorithm to guide clinical workup of metallic implant patients with putative metal hypersensitivity, both before and after implantation. 133, 134 
Preimplant Testing
The approach to a patient with a history of metal allergy, who is considering implantation of a titanium device, should begin with a thorough history. Although immune response to an implant remains unpredictable, patients with a reported history of sensitivity to a metallic device or metal jewelry may be more likely to have an immune response to an implant. 17 Prior reactivity to ''titanium'' jewelry or eyeglass frames is not a reliable source of titanium exposure. If a patient reports a previous hypersensitivity reaction to an implanted ''titanium'' device (eg, plates, screws), it is important to determine the specific alloy, remembering that even commercially pure-grade titanium implants could potentially contain ulterior metal impurities. 5, 119 A MELISA assay will be normal after avoidance of the offending metal. 61, 101, 134 Similarly, lymphocyte reactivity would also be normal preceding implantation of a potential metal allergen and therefore would not serve as a legitimate screening tool. For patients who are planning to receive an implant intended to remain for the rest of their life, and whose removal would be impossible or pose extremely high risk, some type of screening is direly needed. Temporarily implanting an easily retrievable sample of the proposed titanium device may provide guidance, although would not account for mechanical corrosion.
DISCUSSION
Life expectancy is increasing. Inevitably, this demographic change will result in increased use of metallic implant devices. Titanium sensitivity will likely continue to be considered in cases of failed devices, unexplained symptoms, and skin reactions. It is unclear whether prior metal sensitivity can cause implant failure, or implant failure can induce metal sensitivity. In the case of titanium hypersensitivity, it is highly unlikely that patients with only prior cutaneous exposure to titanium are sensitized, given that titanium in its most common form (TiO 2 ) does not penetrate the epidermis. Like all metals, titanium is not completely inert; biocorrosion may occur with titanium implants and, with it, the potential to elicit an immune reaction. Researchers have reported a higher prevalence of titanium hypersensitivity among patients sensitive to other metals. 7, 62, 76 Could a type IV hypersensitivity response to alloy components (such as nickel or cobalt) recruit cells to elicit an immune response to titanium, similar to the coreactions commonly seen with neomycin and bacitracin? Or are patients with titanium sensitivity genetically more prone to be sensitive to all metals? Or do the reported cases of titanium sensitivity simply represent T cell reactivity with no clinical relevance? Complete elucidation of titanium hypersensitivity and its relevance to implant failure will require intensive prospective studies that have not been performed to date, in large part because no standardized diagnostic test exists.
CONCLUSIONS
Titanium allergy appears to be exceptionally rare. In cases of suspected titanium sensitivity, it is prudent to first look for other potential causes such as reactions to alloy components or other metal impurities, particularly nickel. Patch testing is unreliable because of the lack of penetration of titanium salts through the epidermis. Lymphocyte proliferation assays are not widely accepted. The definitive treatment for confirmed titanium hypersensitivity reaction is removal of the device; however, medical management is possible in some cases. There still remains no useful screening tool to predict a potential hypersensitivity reaction to implanted titanium devices, and further investigation is needed.
